This week, the U.S. Supreme Court set a date for one of the highest stakes cases on abortion care this year: accessibility to mifepristone, commonly referred to as “the abortion pill." The Court will start oral arguments for the case U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine on March 26, 2024.
A ruling in favor of Alliance for Hippocratic Medicine, an organization of anti-abortion activists backed by the Christian right-wing lobbying group Alliance Defending Freedom, who brought the case forward, could result in eliminating access to mifepristone by telehealth and by mail, and shortening the timeframe that it could be used for in a pregnancy from 10 weeks to seven weeks.
